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ABSTRACT
It is well known that allergic reactions may sometimes
occur in patients under treatment with b -lactam anti-
biotics. For the detection of antidrug antibodies in
vitro, conjugation with human serum albumin has
been considered to be essential. In this study, we found
that cefotiam, cefpirome, and ceftazidime could be
immobilized without conjugation to carrier protein 
to construct a solid-phase enzyme-linked immuno-
sorbent assay (ELISA) system. We describe a patient
(26-year-old female nurse) with contact urticaria
induced by antibiotics. Using the serum of this patient,
we successfully detected IgE antibody directed to the
aminothiazolyl group of cephalosporins, which has
not previously been reported. Results suggest that the
simple ELISA using unconjugated antibiotics could be
applicable to patients with allergy to some cephalo-
sporins and the aminothiazole side chain of the
cephalosporins could cause an IgE-mediated allergic
reaction.
Key words: antibiotics, contact dermatitis, contact
urticaria, drug allergy, enzyme-linked immunosorbent
assay, immunoglobulin E.
INTRODUCTION
It is well known that allergic reactions may sometimes
occur in patients being treated with b -lactam antibiotics.
There is no doubt that detection of IgE antibody by in vitro
methods is rather more desirable than in vivo methods
such as Prausnitz-Küstner reaction for clinical investigation
of causal compounds. However, new antigenic deter-
minants formed by binding with serum proteins that are
considered to be mostly responsible for the allergic re-
action appear in vivo. In this context, conjugation with
human serum albumin has been considered to be essen-
tial to detect antibodies in immunoassays. Using such
conjugated compounds, the fine structural recognition
pattern has been studied in b -lactam drugs such as 
cefaclor and cephalothin.1,2 Similarly, extensive cross-
reactivity is well known between penicillin and cepha-
losporins in bicyclic nuclear structure (the b -lactam ring).
On this molecular basis, cephalosporins should not be
administered to patients with penicillin allergy.3 The aller-
gic determinants of the drugs are on the cephalosporin
molecule itself rather than on newly formed sites following
conjugation with albumin. These observations are com-
patible with the findings of the basic immunology. Since
most drugs are small molecules and haptens, conjugation
with carrier protein is necessary to induce immunologic
response. In such immunologic response, T cells will 
recognize carrier protein but antibodies will recognize
determinants on hapten. Therefore, if drugs could be
coated on the plates without conjugation with protein, IgE
antibody could be expected to react with the drugs.
In the present study, we tried to immobilize antibiotics
without conjugation to carrier protein and construct a
solid-phase enzyme-linked immunosorbent assay (ELISA)
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system. We also investigated a patient with contact urticaria
induced by a variety of cephem antibiotics. Using the serum
of this patient, we successfully identified the IgE antibody
directed to the common side chain of cephalosporins.
METHODS
Materials
Samples of antibiotics were obtained from two com-
panies. The compounds, 2-aminothiazole (AT), 1H-
tetrazole (TZ) and 2-amino 4-thiazoleacetic acid (ATA)
were purchased from WAKO Pure Chemicals (Osaka,
Japan). Serum was obtained under informed consent
from the patient described below. As control samples,
sera from two patients with bronchial asthma (37-year-
old male with 1383 U/mL of serum IgE, and 41-year-old
female with 4370 U/mL of IgE) and a normal volunteer
(26-year-old male) were also obtained.
Profile of patient with contact urticaria
A 25-year-old nurse was referred to our hospital in July
1997, for further investigation of her contact urticaria.
During the year prior to her visit, she sometimes developed
redness, itching and swelling in her hand and forearm at
the site of contact with antibiotic solutions that she pre-
pared in the course of her work. The symptoms developed
5–10 min after contact with the solution, and disappeared
in 4–5 h. More recently, they had extended to her face,
especially around her eyes. She had hand eczema and had
been treated by a dermatologist 2–3 years previously. She
had not taken cephem antibiotics for at least 10 years. For
9 years she had had an allergy to metal, such as a neck-
lace or a watch, and an allergy to Japanese cedar pollen.
Her height was 148 cm and her weight was 44 kg. Physical
examination showed nothing unusual, except a few rice-
sized lymph node swellings on the right side of her neck.
Laboratory examination showed no abnormality, except
increased serum IgE levels of 460 IU/mL with more than
100 UA/mL of IgE specific to Japanese cedar (by CAP-
RAST). She was notified that contact with antibiotics could
endanger her life. She was advised to keep away from
preparing antibiotic solutions and to wear latex gloves
when she could not avoid preparing these solutions. Since
then, her symptoms have not reappeared.
Determination of specific antibody levels
Specific IgE antibody titers were determined by an
enzyme-linked immunosorbent assay (ELISA).4 Plates
(Costar, Cambridge, MA, USA) were coated with 
300 µg/mL antibiotics (without conjugation to protein)
diluted in saline or 0.1 mol/L NaHCO3 (pH 8.3).
Following overnight incubation at 4°C, the plates were
washed three times and blocked with 1% bovine serum
albumin (BSA; Sigma, St Louis, MO, USA) in PBS for 2 h
at 37°C. Serum samples serially diluted in 1% BSA/PBS
were applied to the blocked wells and incubated over-
night at 4°C. Then the plates were washed and incubated
with horseradish peroxidase (HRP)-conjugated rat anti-
human IgE monoclonal antibodies (Pharmingen, San
Diego, CA, USA) diluted in 50% goat serum (Gibco,
Grand Island, NY, USA) in PBS for 2 h at 37°C. After
washing, wells were developed using OPDA solution
(0.3% o-phenylenediamine dihydrochloride, 0.02% H2O2, 
0.15 mol/L citrate buffer, pH 4.9) and the absorption 
at 492–620 nm was determined using a microplate
autoreader.
To confirm the immobilization of antibiotics, immune
serum was applied instead of human serum in the above
method. Anti-cephalosporin C rabbit serum (Biogenesis
Ltd, Poole, UK), anti-cefpirome (CPR), or anti-cefmeta-
zole (CMZ) rat serum were used as immune sera. The
latter two sera were made in our laboratory according to
a method described previously,5 with some modifications.
Briefly, CPR or CMZ was conjugated with ovalbumin
(grade V; Sigma) and used with complete Freund’s adju-
vant for immunization of rats (8-week-old male Brown
Norway rat) twice at an interval of 2 weeks. Blood was
collected at 10 days after the second immunization. As
secondary antibodies, HRP-conjugated goat anti-rabbit
IgG (Rockland, Gilbertsville, PA, USA) or goat anti-rat
IgG (Chemicon International Inc., Temecula, CA, USA)
were used.
For pre-incubation study, the serum was pre-incubated
with various concentrations of the compounds in wells
blocked with 1% BSA/PBS. After 1 h incubation at room
temperature, serum was added to the plates as a sample.
RESULTS
The patient confirmed that cefotiam (CTM) was one of the
causal drugs. Therefore, CTM was tested first in the ELISA
system. We successfully detected IgE antibody reacting
equally with wells coated with this compound diluted in
both saline and 0.1 mol/L NaHCO3 (pH 8.3) (data not
shown). Since the structure of CTM contains aminothia-
zole and tetrazole side chains, we selected CPR and
CMZ, each of which has one common side chain with
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CTM, to test the specificity. We found that the patient’s
serum IgE reacted with wells coated with CTM or CPR but
not with CMZ. A representative result is shown in Fig. 1.
The structures of the three compounds are shown in Fig.
2. As shown in Fig. 3, anti-CTM IgE antibody was
detected in the serum of the patient described above, but
not in the two atopic asthmatic patients nor in the healthy
volunteer. None of these sera reacted with wells coated by
CMZ. Further reactivity was tested and it was found that the
patient’s serum contained IgE reacting with wells coated by
ceftazidime (CAZ).
To confirm the immobilization of antibiotics on the
plate, we applied immune sera in this ELISA system 
(Table 1). Anti-cephalosporin C antibody reacted with
wells coated with CTM but not CPR, CAZ or CMZ, while
anti-CPR immune serum reacted with wells coated with
CPR or CAZ, but not CTM or CMZ. Anti-CMZ immune
serum did not react with wells coated with either CTM,
CPR, CAZ or CMZ. Therefore, we concluded that CTM,
CPR and CAZ, but not CMZ, could be immobilized
directly to the surface of the plates.
The structure of the ligand for the IgE antibody was
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Fig. 1 Detection of IgE antibody to cefotiam (d) and cef-
pirome (h) but not cefmetazole (n) in the patient’s serum by
enzyme-linked immunosorbent assay.
Fig. 2 Molecular structures
of cefotiam, cefpirome and
cefmetazole.
confirmed by the absorption studies. Pre-incubation with
CTM completely absorbed the reactivity to CTM and
CPR. Similarly, pre-incubation with CPR, aminothia-
zole and amino-thiazoleacetic acid, but not tetrazole,
markedly diminished the reactivity to CTM and CPR 
(Fig. 4). The inhibition of aminothiazole was dose depen-
dent as shown in Fig. 5. There were no differences in the
reactivity of the anti-cephalosporin C antibody to CTM-
coated wells that had been pre-incubated with AT, CTM,
or saline, indicating no possibility that the addition of free
AT or CTM can remove immobilized CTM. The structures
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Fig. 3 The IgE antibody to cefotiam was detected in the
present patient (d) but not patients with elevated levels of IgE or
normal control. Patient 1 (h): bronchial asthma, 37-year-old
male, serum IgE of 1383 IU/L. Patient 2 (n): bronchial asthma
and atopic dermatitis, 41-year-old female, serum IgE of
4370 IU/L. Normal (s): no allergic diseases, 26-year-old
male.
Table 1 Reactivity of various immune sera to immobilized
antibiotics
Fig. 4 Pre-incubation studies. The patient’s serum was tested
for IgE antibody to (a) cefotiam (CTM) and (b) cefpirome (CPR),
following pre-incubation with CTM, CPR, aminothiazole (AT),
amino-thiazoleacetic acid (ATA) and tetrazole (TZ) at concen-
trations of 300 m g/mL. The value of IgE in serum just left for the
pre-incubation time was used as positive control (100%).
Fig. 5 Pre-incubation of serum with aminothiazole at various
concentrations. The patient’s serum was tested for IgE antibody
to cefotiam (CTM). Aminothiazole showed a dose-dependent
inhibition for the reactivity to CTM. The value of IgE in serum
just left for the pre-incubation time was used as positive control
(100%).
Immune serum CTM CPR CMZ CAZ
Anti-cephalosporin C O X X X
Anti-CPR X O X O
Anti-CMZ X X X X
X, negative; O, positive; CTM, cefotiam; CPR, cefpirome; CMZ,
cefmetazole; CAZ, ceftazidime.
of the compounds used in this pre-incubation study are
shown in Fig. 6.
DISCUSSION
In the present study, we tried to immobilize antibiotics alone
(i.e., without conjugation with protein) for an ELISA system
to test whether specific IgE could be detected in this system.
Direct detection using serum from a patient with drug-
induced contact urticaria demonstrated IgE antibody
reacting with the aminothiazole side chain of the cephalo-
sporins. Because the coating of the solid phase was done
by simple adsorption, it was essential to ensure sufficient
absorption by a plastic surface. By using anti-cephalo-
sporin C and anti-CPR immune serum, we confirmed the
immobilization of CTM, CPR and CAZ. Thus, conjugation
with protein, such as human serum albumin, may not be
needed for these antibiotics at least. From the results of
direct detection, there is a possibility that the serum of our
patient had reactivities other than the aminothiazole side
chain. However, inhibition studies revealed that the
aminothiazole side chain would be a major antigenic
determinant for the reactivity to CTM or CPR.
The present ELISA system has some obvious limitations.
First, immobilization could not be achieved for all anti-
biotics. Our results indicated that certain antibiotics such
as CMZ cannot be immobilized. Second, this method
cannot be applied to new determinants formed by inter-
action between compounds and carrier protein, such
as albumin. Mizutani et al. have reported that the IgE
fraction of their patient’s serum contained IgE that recog-
nized CTM linked to human serum albumin but not to
CTM or albumin alone.6 In spite of these limitations,
omission of protein conjugation would be convenient for
in vitro search for the responsible compounds in patients
with IgE-mediated allergy to cephalosporin.
Several reports concerning antigenic site on cephal-
osporins have been published. Foti et al. have reported
the results of a patch test with different cephalosporins in
18 occupationally exposed nurses with contact derma-
titis.7 Positive results were obtained in seven patients. The
common structure was the tetrazolic group in six of them,
and the aminothiazolyl group in one patient.7 Similarly, 
in patients with drug-induced fever or skin eruption, the
tetrazolyl group was reported to have a major respon-
sibility in type IV allergy determined by the leukocyte
migration inhibition test.8 Therefore, a tetrazolyl group
may be a major allergen in these patients.
Contact urticaria has been described for more
than 20 years.9,10 It can be primarily divided into
immunologic and non-immunologic types. Because
immunologic-contact urticaria may cause not only local
skin lesion but also non-cutaneous involvement such as
asthma and anaphylaxis, it is important for physicians to
bear it in mind. Many agents are reported to cause
immunologic-contact urticaria, including food, animals,
plants, industrial chemicals and medicaments. Among
the medical agents, antibiotics are unique because
medical staff can be occupationally exposed to them. In
Japan, there are 14 case reports of contact urticaria
caused by occupational exposure to antibiotics, as
reviewed by Shimizu et al.11 All were nurses and, inter-
estingly, a common causal drug was CTM. Because
CTM at least can apply in the present ELISA system, 
this ELISA method would be useful for such patients,
although simple immobilization cannot be achieved 
for all antibiotics. Among reported cases, IgE directed 
to CTM conjugated with HSA was demonstrated in
only three cases.6,12 All of these patients had IgE 
directing to tetrazolic ring on CTM. Using the prick test,
suspected cross-reactivity to tetrazole was demonstrated
in nine of nine cases in previous studies.11,13–15 There-
fore, the usual structure of cephalosporins reacting with
IgE was tetrazolic ring. Our patient seems to be the first
case demonstrating aminothiazole as an allergen for con-
tact urticaria. However, it should be noted that the results
may be influenced by the detection system, for which the
present case was different from previous studies.
In conclusion, an ELISA system could be constructed
with some particular antibiotics immobilized in solid phase
without carrier protein conjugation. Using this system, we
detected IgE antibody reacting with aminothiazole on
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Fig. 6 Molecular structures of aminothiazole, amino-
thiazoleacetic acid and tetrazole.
cephalosporin molecule; accordingly, it may be useful for
detection of antibodies to drugs in patients with an aller-
gic reaction to cephalosporins.
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